Saw Palmetto Extract in Benign Prostatic Hyperplasia

PHASE3CompletedINTERVENTIONAL

Enrollment

224

Participants

Timeline

Start Date

August 31, 1999

Study Completion Date

December 31, 2002

Conditions

Benign Prostatic Hyperplasia

Interventions

DRUG

Saw Palmetto

Trial Locations (2)

Veterans Affairs Medical Center, San Francisco

Northern California Kaiser Permanente, Oakland

All Listed Sponsors

collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00037154 - Saw Palmetto Extract in Benign Prostatic Hyperplasia | Biotech Hunter | Biotech Hunter